IL-1β participates in a feedback loop in several human cancers, promoting tumor immune escape via increased PD-L1 expression, the secretion of macrophage-recruiting proteins, the acquisition of malignant characteristics by tumor cells, and worse patient prognosis (83–86). Here, CD274 is linked to neoplasm.